Issued 2026-09-16 at $56.31 · now $56.31 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, MSEX has typically landed between $48.71 and $63.18 — a range of −13.5% to +12.2% from the issuance price $56.31.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
5,003 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($56.31) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where MSEX has typically landed a month from the 2026-09-16 close of $56.31 — the range is history, not a prediction.
- now $56.31 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $56.12 (-0.3%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $53.26–$58.98
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $48.71–$63.18
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2009-02-05 | −31.2% | −31.2% | +0.7% |
| 2020-02-13 | −28.8% | −28.8% | +0.0% |
| 2009-02-03 | −26.8% | −26.8% | +0.0% |
| 3 best | |||
| 2021-07-07 | +32.0% | −0.7% | +32.0% |
| 2021-07-08 | +30.9% | +0.0% | +32.9% |
| 2021-07-06 | +29.6% | +0.0% | +29.6% |
5,003 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-07 | Ginegaw Lorrie Beth | officer | Sale | 615 @ $57.61 | $35K | −13.4% of holding | +1.1% | not yet — horizon still open | 3,978 | Form 4 · filed same day |
| 2026-03-04 | REINHARD WALTER G | director | Sale | 300 @ $55.21 | $17K | −4.7% of holding | +1.0% | −7.1% | 6,051 | Form 4 · filed same day |
| 2026-02-27 | HOGLUND ROBERT N | director | Purchase | 2,000 @ $54.31 | $109K | ownership Δ n/a | +5.3% | −3.7% | 2,000 | Form 4 · filed same day |
| 2026-02-25 | Capko Robert John | officer | Sale | 134 @ $54.04 | $7K | −100.0% of holding | +2.0% | −3.2% | 0 | Form 4 · filed same day |
| 2025-11-18 | Ginegaw Lorrie Beth | officer | Sale | 650 @ $50.92 | $33K | −14.9% of holding | +3.4% | −9.3% | 3,709 | Form 4 · filed same day |
| 2025-05-28 | REINHARD WALTER G | director | Sale | 702 @ $57.37 | $40K | −100.0% of holding | −10.0% | −26.2% | 0 | Form 4 · filed 1 day after the trade |
| 2025-03-21 | Doll Dennis W | director | Sale | 4,067 @ $60.05 | $244K | −7.2% of holding | +12.0% | −28.6% | 52,112 | Form 4 · filed 3 days after the trade |
| 2025-03-11 | REINHARD WALTER G | director | Sale | 300 @ $64.41 | $19K | −4.5% of holding | −2.9% | −32.8% | 6,351 | Form 4 · filed same day |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
66 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-11 | Bershad Joshua | director | Other acquisition | 6,900 | 223,798 | Form 4 |
| 2026-04-01 | Duchemin-Leslie Nadine | director | Award / grant | 12,675 | 19,352 | Form 4 |
| 2026-04-01 | Zerhouni Mohammed G. | officer | Award / grant | 5,927 | 9,047 | Form 4 |
| 2026-04-01 | Sorensen Gregory S | officer | Award / grant | 4,983 | 4,983 | Form 4 |
| 2026-04-01 | Kooper Jay L | officer | Award / grant | 2,597 | 7,450 | Form 4 |
| 2026-04-01 | Simpson Georgia M | officer | Award / grant | 2,140 | 6,323 | Form 4 |
| 2026-04-01 | Fullagar Robert K | officer | Award / grant | 2,128 | 7,319 | Form 4 |
| 2026-04-01 | Ginegaw Lorrie Beth | officer | Award / grant | 2,017 | 6,251 | Form 4 |
| 2026-04-01 | Capko Robert John | officer | Award / grant | 1,679 | 3,641 | Form 4 |
| 2026-04-01 | Fullagar Robert K | officer | Other acquisition | 886 | 6,433 | Form 4 |
| 2026-04-01 | Bershad Joshua | director | Award / grant | 865 | 1,567 | Form 4 |
| 2026-04-01 | NOBLE ANN L. | director | Award / grant | 865 | 865 | Form 4 |
| 2026-04-01 | McKoy Vaughn L | director | Award / grant | 865 | 865 | Form 4 |
| 2026-04-01 | Mansue Amy B. | director | Award / grant | 865 | 865 | Form 4 |
| 2026-04-01 | Cosgrove James F. Jr. | director | Award / grant | 865 | 865 | Form 4 |
| 2026-04-01 | REINHARD WALTER G | director | Award / grant | 865 | 865 | Form 4 |
| 2026-04-01 | Klein Steven M | director | Award / grant | 865 | 3,333 | Form 4 |
| 2026-04-01 | HOGLUND ROBERT N | director | Award / grant | 865 | 865 | Form 4 |
| 2026-04-01 | Hanemann Kim C | director | Award / grant | 865 | 3,367 | Form 4 |
| 2026-04-01 | Ginegaw Lorrie Beth | officer | Other acquisition | 823 | 5,428 | Form 4 |
| 2026-04-01 | Kooper Jay L | officer | Other acquisition | 759 | 6,691 | Form 4 |
| 2026-04-01 | Simpson Georgia M | officer | Other acquisition | 759 | 5,564 | Form 4 |
| 2026-04-01 | Fullagar Robert K | officer | Withheld for tax | 394 | 1,297 | Form 4 |
| 2026-04-01 | Ginegaw Lorrie Beth | officer | Withheld for tax | 364 | 4,593 | Form 4 |
| 2026-04-01 | Kooper Jay L | officer | Withheld for tax | 350 | 878 | Form 4 |
| 2026-04-01 | Simpson Georgia M | officer | Withheld for tax | 338 | 1,057 | Form 4 |
| 2026-04-01 | Capko Robert John | officer | Other acquisition | 193 | 3,448 | Form 4 |
| 2026-04-01 | Capko Robert John | officer | Withheld for tax | 83 | 83 | Form 4 |
| 2026-03-03 | Duchemin-Leslie Nadine | director | Other acquisition | 4,630 | 6,677 | Form 4 |
| 2026-03-03 | Duchemin-Leslie Nadine | director | Withheld for tax | 2,336 | 7,129 | Form 4 |
| 2026-03-01 | Duchemin-Leslie Nadine | director | Award / grant | 4,630 | 11,307 | Form 4 |
| 2025-06-15 | Bershad Joshua | director | Other acquisition | 213,365 | 230,698 | Form 4 |
| 2025-04-01 | Duchemin-Leslie Nadine | director | Award / grant | 6,677 | 6,677 | Form 4 |
| 2025-04-01 | Zerhouni Mohammed G. | officer | Award / grant | 3,120 | 3,120 | Form 4 |
| 2025-04-01 | Kooper Jay L | officer | Award / grant | 1,607 | 5,685 | Form 4 |
| 2025-04-01 | Fullagar Robert K | officer | Award / grant | 1,404 | 5,878 | Form 4 |
| 2025-04-01 | Simpson Georgia M | officer | Award / grant | 1,123 | 4,885 | Form 4 |
| 2025-04-01 | Ginegaw Lorrie Beth | officer | Award / grant | 1,014 | 5,177 | Form 4 |
| 2025-04-01 | Ginegaw Lorrie Beth | officer | Other acquisition | 943 | 4,234 | Form 4 |
| 2025-04-01 | Capko Robert John | officer | Award / grant | 889 | 2,173 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.